You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>IMS</strong> COM PANY PRO FILES TAKEDA SUBSIDIARY LISTING<br />
Phar ma ceu ti cal Sales: US$ 55-60 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 80-85%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 85-90%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
ACTOS (antidiabetic oral)<br />
TAKEPRON OD (antiulcerant)<br />
BLOPRESS (an gio ten sin-II an tag o nist plain)<br />
LEUPLIN DE POT (cytostatic hor mone)<br />
SHIN BIOFERMIN S (antidiarrheal mi cro-or gan -<br />
ism)<br />
Ther a peu tic Range:<br />
drugs used in di a be tes 31%<br />
ant ac ids/antiflatulents/antiulcerants 20%<br />
cytostatic hor mone ther apy 15%<br />
renin-an gio ten sin sys tem agents 14%<br />
antidiarrheals, elec tro lyte re plac ers, in tes ti nal<br />
anti-inflammatorie s 8%<br />
Lead ing Dose Forms:<br />
tab lets 75%<br />
vi als 15%<br />
coated tab lets 6%<br />
cap sules 2%<br />
pow ders/gran ules 1%<br />
� THAILAND<br />
TAKEDA<br />
Full Name: Takeda (Thai land) Ltd<br />
Street Ad dress: 10th Floor, Rajanakarn Bldg.,<br />
183 South Sathorn Road, Kwang Yannawa, Khet<br />
Sathorn, Bang kok 10120<br />
Tel: +66 2 676 6770<br />
Fax: +66 2 676 6770<br />
Sub sid iary of: Takeda, Ja pan (48%)<br />
Phar ma ceu ti cal Sales: US$ 55-60 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 85-90%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 90-95%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
ACTOS (antidiabetic oral)<br />
MADIPLOT (cal cium an tag o nist plain)<br />
PREVACID (antiulcerant)<br />
BLOPRESS (an gio ten sin-II an tag o nist plain)<br />
ENANTONE L.P. (cytostatic hor mone)<br />
Ther a peu tic Range:<br />
drugs used in di a be tes 26%<br />
ant ac ids/antiflatulents/antiulcerants 22%<br />
cal cium an tag o nists 21%<br />
renin-an gio ten sin sys tem agents 16%<br />
cytostatic hor mone ther apy 9%<br />
Lead ing Dose Forms:<br />
tab lets 88%<br />
vi als 10%<br />
coated tab lets 1%<br />
liq uids 1%<br />
am poules -<br />
� UK<br />
MIL LEN NIUM<br />
Full Name: Mil len nium Pharmaceuticals, Ltd.<br />
Street Ad dress: Build ing 3, Chis wick Park, 566<br />
Chis wick High Road, Chis wick, Lon don, W4 5YA<br />
Tel: +44 20 8849 8060<br />
Fax: +44 20 8849 5580<br />
Email: info_eu@mlnm.com<br />
Home Page: www.mlnm.com<br />
De scrip tion: Re searcher. Prod uct ranges in -<br />
clude: phar ma ceu ti cal prod ucts, di ag nos tic prod -<br />
ucts. Es tab lished 2000.<br />
Con tacts (Pharm): Chair man: Dr Alan<br />
Marchington; Com mer cial Op er a tions: Sean<br />
Cush; Re search & De vel op ment: Dr Da vid<br />
Tapolczay; Gen eral Con tact: Julia Wilson<br />
Sub sid iary of: Mil len nium, USA<br />
TAKEDA<br />
Full Name: Takeda UK Ltd<br />
Street Ad dress: Takeda House, Mer cury Park,<br />
Wycombe Lane, Wooburn Green, High Wycombe,<br />
Buckinghamshire HP10 0HH<br />
Tel: +44 1628 537900<br />
Fax: +44 1628 526615<br />
Home Page: www.takeda.co.uk<br />
De scrip tion: De vel oper, dis trib u tor, pro moter,<br />
sales/detailer. Prod uct ranges in clude: phar ma -<br />
ceu ti cal prod ucts (branded, pre scrip tion), hos pi tal<br />
pharmaceuticals. Es tab lished 1997.<br />
Con tacts (Pharm): Chair man: An drew Da vis;<br />
Com mer cial Op er a tions: Mark Mor ri son, Trevor<br />
Smith; Mar ket Re search: Mark Mor ri son; Re -<br />
search & De vel op ment: Jay Herbert<br />
Sub sid iary of: Takeda, Neth er lands (100%)<br />
Phar ma ceu ti cal Sales: US$ 200-210 mil lion<br />
Prod ucts (% of Sales by Lead ing 5):<br />
95-100%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): n.a.<br />
Dose Forms (% of Sales by Lead ing 5): n.a.<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 129
Change language